Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen J. Hill currently holds 65,000 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen J. Hill has been a net seller of LYEL stock. They have purchased $0 and sold $16.6K worth of shares.
Stephen J. Hill's most recent insider trade was on Feb 10, 2026, when they sold 65,000 shares at $0.00 per share.
Stephen J. Hill serves as Executive at Lyell Immunopharma, Inc. (LYEL). They have executed 10 insider transactions totaling $16.6K over their tenure at the company.
Stephen J. Hill holds the position of Executive at Lyell Immunopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Stephen J. Hill has shown a selling trading pattern, with $0 in total purchases and $16.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen J. Hill was on Aug 21, 2025, when they sold $10.6K worth of LYEL shares. This transaction involved 1,004 shares at $10.54 per share.
Stephen J. Hill currently owns 65,000 shares of Lyell Immunopharma, Inc. (LYEL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen J. Hill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen J. Hill has 10 Form 4 filings on record as an insider at Lyell Immunopharma, Inc..
Set alerts for Stephen J. Hill and 40,000+ other insiders.